174 related articles for article (PubMed ID: 29564133)
1. Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma.
Arribas Arranz J; Winter DN; Drexler HG; Eberth S
Biomark Res; 2018; 6():11. PubMed ID: 29564133
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.
Morales-Martinez M; Valencia-Hipolito A; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Martinez-Maza O; Huerta-Yepez S; Vega MI
Oncotarget; 2019 Mar; 10(22):2173-2188. PubMed ID: 31040909
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1.
Morales-Martinez M; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Huerta-Yepez S; Vega MI
Front Oncol; 2020; 10():588893. PubMed ID: 33194748
[TBL] [Abstract][Full Text] [Related]
4. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
[TBL] [Abstract][Full Text] [Related]
5. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study.
Hafsi S; Candido S; Maestro R; Falzone L; Soua Z; Bonavida B; Spandidos DA; Libra M
Oncol Lett; 2016 Feb; 11(2):1021-1025. PubMed ID: 26893685
[TBL] [Abstract][Full Text] [Related]
7. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
8. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B
Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714
[TBL] [Abstract][Full Text] [Related]
9. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
[TBL] [Abstract][Full Text] [Related]
10. KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent.
Montecillo-Aguado M; Morales-Martínez M; Huerta-Yepez S; Vega MI
Leuk Lymphoma; 2021 Jun; 62(6):1422-1431. PubMed ID: 33410342
[TBL] [Abstract][Full Text] [Related]
11. YY1 expression predicts favourable outcome in follicular lymphoma.
Naidoo K; Clay V; Hoyland JA; Swindell R; Linton K; Illidge T; Radford JA; Byers RJ
J Clin Pathol; 2011 Feb; 64(2):125-9. PubMed ID: 21109702
[TBL] [Abstract][Full Text] [Related]
12. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
[TBL] [Abstract][Full Text] [Related]
13. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
14. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y
Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Hongo F; Garban H; Huerta-Yepez S; Vega M; Jazirehi AR; Mizutani Y; Miki T; Bonavida B
Biochem Biophys Res Commun; 2005 Oct; 336(2):692-701. PubMed ID: 16143308
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma.
Luo C; Chen X; Bai Y; Xu L; Wang S; Yao L; Guo X; Wang D; Zhong X
Int J Genomics; 2022; 2022():9305081. PubMed ID: 35359580
[TBL] [Abstract][Full Text] [Related]
17. Yin Yang 1 Dynamically Regulates Antiviral Innate Immune Responses During Viral Infection.
Zan J; Zhang H; Gu AP; Zhong KL; Lu MY; Bai XX; Zhang JY; Cai J
Cell Physiol Biochem; 2017; 44(2):607-617. PubMed ID: 29161701
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor yin-Yang 1 augments nucleoporin 93 oncogene activity and modulates bladder Cancer malignancy.
Zhang G; Wei W; Li S; Yang J
Toxicol In Vitro; 2024 Jun; ():105875. PubMed ID: 38857852
[TBL] [Abstract][Full Text] [Related]
19. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
Zhao L; Li R; Gan YH
Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
